# PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results

- Source: PR Newswire M&A
- Published: 2026-10-29T20:01:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/ptc-therapeutics-provides-corporate-update-and-reports-third-quarter-2026-financial-results-302924188.html
- Canonical: https://groundlevelnews.com/story/ptc-therapeutics-provides-corporate-update-and-reports-third-quarter-2-4b2ef8/

– Strong Q3 2026 performance with total revenue of $358 million, including $276 million of product revenue – – Full-year 2026 expected total revenue increased to $1.29 to $1.32 billion, with full-year product revenue guidance raised to $960 to $990 million – – Sephience™ (sepiapterin) Q3...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._